Clinical Trial Supply and Logistics Market Report 2025 (Global Edition)

Global Clinical Trial Supply and Logistics Market Report 2025 Market Size Split by Service (Logistics & Distribution, Storage & Retention, Packaging, Labeling, and Blinding, Manufacturing, Comparator ...

Clinical Trial Supply and Logistics Market Report Description

We have various report editions of Clinical Trial Supply and Logistics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Clinical Trial Supply and Logistics Market Insights Video

Competitive Landscape of Clinical Logistics Market

The market for Clinical Logistics has a very active and diverse competitive environment. It comprises various clinical logistics providers, from significant multinational corporations to smaller specialized organizations. Due to globalization and technological development, there is fierce competition among businesses to provide cutting-edge solutions in Clinical Logistics Market. 

• July 2022: DHL Freight is growing its network in Germany by acquiring a new terminal located in Mettmann near Dusseldorf, Germany.

(Source:www.dpdhl.com/en/media-relations/press-releases/2022/dhl-freight-acquisition-of-freight-facility-near-dusseldorf-germany.html)

• August 2022: Catalent, a prominent player in clinical supply services worldwide, recently revealed its agreement to purchase a clinical packaging facility in Minakuchi, Shiga prefecture, Japan. Teva-Takeda Pharmaceuticals currently owns the facility, based in Nagoya Aichi, Japan.

(Source:www.catalent.com/catalent-news/catalent-announces-acquisition-of-japanese-facility-to-provide-local-and-global-clinical-supply-solutions/#:~:text=SOMERSET%2C%20N.J.%20%E2%80%93%20May%2021%2C,Pharmaceuticals%2C%20Nagoya%20Aichi%2C%20Japan.)

Top Companies Market Share in Clinical Trial Supply and Logistics Industry: (In no particular order of Rank)

• Thermo Fisher Scientific (Patheon)
• Catalent
• Inc.
• Parexel
• Almac Group
• Marken
• Piramal Pharma Solutions
• UDG Healthcare
• DHL
• FedEx
• Movianto
• Packaging Coordinators Inc.
• Inizio Group Limited
• Parexel International Corporation
• Deutsche Post DHL Group
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

The North American region holds the Largest Share of the Clinical Logistics market

According to Cognitive Market Research, North America asserts dominance in the Clinical Logistics Market due to its advanced healthcare infrastructure, robust research and development capabilities, and a concentration of pharmaceutical and biotechnology companies. The United States (USA) stands out as the dominant country in this region due to several key factors. The USA boasts a thriving pharmaceutical and biotech industry with many clinical trials across diverse therapeutic areas. Its well-established regulatory framework and efficient logistics networks facilitate the transportation of investigational products, samples, and supplies across the vast country. Additionally, the USA's innovative approach to healthcare and its emphasis on cutting-edge research and technology-driven solutions align well with the demands of the Clinical Logistics Market. The presence of numerous prestigious research institutions, top-tier healthcare facilities, and a culture of innovation further cements the USA's position as the dominant player in this field.

Due to a confluence of factors that are transforming healthcare landscapes around the region, the Clinical Logistics Market is expanding quickly in the Asia-Pacific region. A spike in clinical research and trials is being caused by the growing population, increased prevalence of chronic illnesses, and rising demand for improved healthcare solutions. Asia-Pacific nations have made investments in medical research and infrastructure, including India, China, Japan, and South Korea. As a result, the region is becoming a hub for clinical trials, attracting domestic and international pharmaceutical and biotechnology companies seeking diverse patient populations and cost-effective research settings.

The current report Scope analyzes Clinical Trial Supply and Logistics Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

Clinical Trial Supply and Logistics Market Analysis

Service Segment Analysis

According to Cognitive Market Research, the logistics & distribution segment likely dominates due to its crucial role in ensuring the seamless movement of clinical trial materials, drugs, and supplies across diverse geographical locations. Efficient logistics and distribution services are essential to maintain the integrity of clinical trials, ensuring timely delivery of investigational products to various trial sites while adhering to stringent regulations. These services encompass temperature-controlled shipping, customs clearance, and secure transportation, all of which are pivotal to preserving the quality and reliability of clinical trial materials. 

The comparator sourcing segment is anticipated to be the fastest-growing category. Comparator sourcing involves procuring reference products for comparative studies in clinical trials, often requiring careful matching and strict quality control. The demand for comparator-sourcing services surges as clinical trials become more complex and encompass broader geographic regions. With increasing emphasis on cost-effectiveness, quality assurance, and regulatory compliance, comparator sourcing services address a critical need within the clinical logistics landscape.

• Logistics & Distribution
• Storage & Retention
• Packaging
• Labeling
• and Blinding
• Manufacturing
• Comparator Sourcing
• Other

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Clinical Trial Supply and Logistics Industry. Request a Free Sample PDF!

End-user Segment Analysis

According to Cognitive Market Research, the pharmaceuticals segment is likely the dominant category due to the extensive drug development activities and the complex supply chain requirements associated with clinical trials conducted by pharmaceutical companies. The rigorous testing, regulatory compliance, and global nature of pharmaceutical clinical trials necessitate specialized logistics solutions to ensure the safe and efficient transport of investigational products, samples, and supplies to multiple trial sites across diverse regions. 

The biological segment is expected to be the fastest-growing category. Biological products, including vaccines, gene therapies, and biopharmaceuticals, are increasingly integral to modern medicine. As the demand for innovative and personalized treatments grows, clinical trials involving biological products surge, driving the need for specialized logistics services that cater to their unique storage and handling requirements.

• Pharmaceuticals
• Biologicals
• Medical Device

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Clinical Trial Supply and Logistics Phase Segment Analysis

The translation is the Clinical Logistics market's most popular offering. The phase III segment is likely dominant, primarily due to its pivotal role in drug development and regulatory approval. Phase III clinical trials involve large patient populations and extensive testing to evaluate investigational drugs' safety, efficacy, and overall benefit-risk profile. 

According to Cognitive Market Research, the phase II segment is expected to be the fastest-growing category. Phase II trials mark a critical juncture where initial safety and efficacy data are gathered to determine dosages, refine the drug's effects, and identify potential adverse reactions. As experimental treatments advance to phase II, the demand for clinical logistics services increases.

• Phase I
• Phase II
• Phase III
• Phase IV

Clinical Trial Supply and Logistics Area Segment Analysis

According to Cognitive Market Research, oncology is likely the dominant category, driven by the extensive clinical trials associated with cancer research and treatment development. Oncology trials often involve complex protocols, multiple trial sites, and diverse patient populations, necessitating meticulous logistics planning to ensure the timely and secure delivery of investigational products and samples.

The category projected to experience the highest growth is cardiovascular diseases. Globally, cardiovascular diseases are a major cause of death, resulting in an increased demand for advanced treatments and therapies. Clinical trials targeting cardiovascular diseases require effective logistics support to facilitate the distribution of investigational products and the collection of patient samples across various trial sites. 

• Oncology
• Cardiovascular Diseases
• Respiratory Diseases
• CNS and Mental Disorders
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion